Trials / Completed
CompletedNCT04361136
Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream
A Phase 1 Clinical Trial to Evaluate the Phototoxic Potential of Delgocitinib Cream After Single Topical Occlusive Application on Healthy Skin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This is a single-centre, randomised, vehicle-controlled, double-blind, within-subject comparison phase 1 clinical trial. The trial is designed to find out if delgocitinib cream can cause skin irritation after light exposure in people with healthy skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Delgocitinib cream | Cream for topical application |
| DRUG | Delgocitinib cream vehicle | The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient. |
Timeline
- Start date
- 2020-04-23
- Primary completion
- 2020-05-30
- Completion
- 2020-05-30
- First posted
- 2020-04-24
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04361136. Inclusion in this directory is not an endorsement.